News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
616,220 Results
Type
Article (24724)
Company Profile (183)
Press Release (591311)
Multimedia
Podcasts (136)
Webinars (19)
Section
Business (210221)
Career Advice (1079)
Deals (32999)
Drug Delivery (129)
Drug Development (70596)
Employer Resources (83)
FDA (13202)
Job Trends (12004)
News (305805)
Policy (25940)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (967)
Accelerated approval (46)
ADA (39)
Adcomms (25)
Allergies (161)
Alliances (44154)
ALS (159)
Alzheimer's disease (1418)
Antibody-drug conjugate (ADC) (416)
Approvals (13707)
Artificial intelligence (596)
ASCO (246)
Autoimmune disease (270)
Automation (44)
Bankruptcy (343)
Best Places to Work (8827)
BIO (61)
BIOSECURE Act (16)
Biosimilars (204)
Biotechnology (116)
Bladder cancer (166)
Brain cancer (57)
Breast cancer (669)
Cancer (5032)
Cardiovascular disease (470)
Career advice (900)
Career pathing (28)
CAR-T (242)
CDC (20)
Celiac Disease (1)
Cell therapy (700)
Cervical cancer (43)
Clinical research (62883)
Collaboration (1923)
Commercialization (1)
Company closure (2)
Compensation (1460)
Complete response letters (85)
COVID-19 (1493)
CRISPR (90)
C-suite (1105)
Cystic fibrosis (130)
Data (7043)
Decentralized trials (2)
Denatured (32)
Depression (144)
Dermatology (81)
Diabetes (540)
Diagnostics (5132)
Digital health (47)
Diversity (9)
Diversity, equity & inclusion (23)
Drug discovery (305)
Drug pricing (202)
Drug shortages (34)
Duchenne muscular dystrophy (260)
Earnings (84494)
Editorial (55)
Employer branding (10)
Employer resources (82)
Events (104871)
Executive appointments (997)
FDA (16470)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (21)
Frontotemporal dementia (28)
Funding (1395)
Gene editing (185)
Generative AI (52)
Gene therapy (553)
GLP-1 (969)
Government (2408)
Grass and pollen (5)
Guidances (351)
Healthcare (12228)
Hematology (137)
HIV (69)
Huntington's disease (40)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (97)
Immunology and inflammation (269)
Immuno-oncology (93)
Indications (193)
Infectious disease (1775)
Inflammatory bowel disease (193)
Inflation Reduction Act (11)
Influenza (101)
Intellectual property (293)
Interviews (149)
IPO (14925)
IRA (49)
Job creations (3498)
Job search strategy (789)
JPM (54)
Kidney cancer (20)
Labor market (85)
Layoffs (397)
Leadership (34)
Legal (7099)
Liver cancer (65)
Longevity (23)
Lung cancer (698)
Lymphoma (377)
Machine learning (46)
Management (32)
Manufacturing (1016)
Marketing (7)
MASH (189)
Medical affairs (1)
Medical device (9817)
Medtech (9945)
Mergers & acquisitions (19271)
Metabolic disorders (1475)
mRNA (145)
Multiple sclerosis (151)
NASH (20)
Neurodegenerative disease (363)
Neuropsychiatric disorders (97)
Neuroscience (2717)
Neurotech (1)
NextGen: Class of 2026 (4317)
Non-profit (1446)
Now hiring (53)
Obesity (720)
Opinion (236)
Ovarian cancer (184)
Pain (256)
Pancreatic cancer (260)
Parkinson's disease (311)
Partnered (27)
Patents (607)
Patient recruitment (620)
Peanut (55)
People (53464)
Pharmaceutical (50)
Pharmacy benefit managers (29)
Phase 1 (19317)
Phase 2 (27832)
Phase 3 (20609)
Pipeline (8574)
Policy (261)
Postmarket research (2220)
Preclinical (7997)
Press Release (50)
Prostate cancer (267)
Psychedelics (43)
Radiopharmaceuticals (313)
Rare diseases (983)
Real estate (4877)
Recruiting (36)
Regulatory (21103)
Reports (34)
Research institute (1122)
Resumes & cover letters (169)
Rett syndrome (40)
RNA editing (21)
RSV (74)
Schizophrenia (174)
Series A (248)
Series B (174)
Service/supplier (7)
Sickle cell disease (102)
Special edition (25)
Spinal muscular atrophy (124)
Sponsored (22)
Startups (3104)
State (2)
Stomach cancer (15)
Supply chain (121)
Tariffs (97)
The Weekly (101)
Vaccines (645)
Venture capital (106)
Weight loss (472)
Women's health (105)
Worklife (10)
Date
Last 7 days (404)
Last 30 days (1579)
Last 365 days (25698)
2026 (14399)
2025 (25755)
2024 (29803)
2023 (33575)
2022 (43010)
2021 (45885)
2020 (42293)
2019 (32099)
2018 (24435)
2017 (26494)
2016 (25274)
2015 (31177)
2014 (27094)
2013 (23354)
2012 (25382)
2011 (25565)
2010 (24803)
Location
Africa (549)
Alabama (79)
Alaska (2)
Arizona (329)
Arkansas (13)
Asia (33195)
Australia (4474)
California (12666)
Canada (3815)
China (1156)
Colorado (517)
Connecticut (491)
Delaware (294)
Europe (63762)
Florida (1931)
Georgia (396)
Hawaii (2)
Idaho (49)
Illinois (918)
India (92)
Indiana (601)
Iowa (16)
Japan (579)
Kansas (117)
Kentucky (38)
Louisiana (34)
Maine (28)
Maryland (1353)
Massachusetts (8824)
Michigan (323)
Minnesota (606)
Mississippi (5)
Missouri (101)
Montana (34)
Nebraska (21)
Nevada (118)
New Hampshire (77)
New Jersey (3282)
New Mexico (28)
New York (3203)
North Carolina (1575)
North Dakota (5)
Northern California (6305)
Ohio (338)
Oklahoma (17)
Oregon (31)
Pennsylvania (2511)
Puerto Rico (32)
Rhode Island (37)
South America (816)
South Carolina (79)
South Dakota (1)
Southern California (5196)
Tennessee (151)
Texas (2095)
United States (43548)
Utah (381)
Vermont (1)
Virginia (262)
Washington D.C. (58)
Washington State (995)
West Virginia (2)
Wisconsin (125)
Wyoming (2)
616,220 Results for "cardiome pharma corp formerly nortran pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals
July 16, 2026
·
9 min read
Press Releases
PharmaCorp Announces Definitive Agreement to Acquire Western Canada PharmaChoice Bannered Pharmacy
• Purchase price of approximately $2.47 million • Second of four previously announced letters of intent (LOIs) converted into a definitive agreement • On closing, expected to increase PharmaCorp’s store count to 16 pharmacies, assuming completion of previously announced acquisitions
June 29, 2026
·
8 min read
Press Releases
Arna Pharma Inc. and Slate Run Pharmaceuticals Finalize Joint Venture and Launch First Brand Product
May 14, 2026
·
3 min read
Manufacturing
Amid $55B US manufacturing push, J&J turns to streamlining its pharma supply chain
After committing $55 billion last year to bolster U.S. manufacturing capabilities, Johnson & Johnson is making changes to its pharmaceutical supply chain.
July 15, 2026
·
1 min read
·
Gabrielle Masson
Press Releases
Nxera Pharma’s Partner Centessa Pharmaceuticals to be Acquired by Lilly
April 1, 2026
·
4 min read
Business
Lilly is pharma’s top dog, placing first in innovation and invention: IDEA
Eli Lilly is the first pharma company to take first place in both categories in the eight years that intelligence firm IDEA Pharma has put out its analysis. Skyrocketing sales and multiple FDA approvals helped the company shoot to the top.
May 26, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Scryb Inc. Changes Name to NorthPalm Capital Corp. and Announces New Trading Symbols
May 5, 2026
·
2 min read
Business
Deep dive: Pharma CEO compensation report
Who is the highest paid CEO in all of pharma? In this special edition,
BioSpace
examines top paid CEOs and their pay packages.
June 30, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
Orvida Pharma (formerly Kamari Pharma) Announces Favorable Phase 1a Safety Data for KM-023, a Potential First-in-Disease Oral TRPV3 Inhibitor, and Initiation of Phase 1b Study in Patients with Olmsted Syndrome
April 15, 2026
·
3 min read
Mergers & acquisitions
Lilly’s $25B+ M&A spree captures half of pharma’s 2026 capacity
Over the past decade, Eli Lilly has bought out more biotechs than any of the other top 12 pharmas by revenue—with 10 of those acquisitions arriving just this year.
June 10, 2026
·
1 min read
·
Annalee Armstrong
1 of 61,622
Next
